Related Experiment Video
Updated: Jan 10, 2026
Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue
Published on: January 6, 2012
Mechanistic Insights into the Anti-Inflammatory and Anti-Proliferative Effects of Selected Medicinal Plants in
Oliwia Burdan1, Natalia Picheta1, Julia Piekarz1
1Students Scientific Association-I Chair and Department of Gynaecological Oncology and Gynaecology, Medical University of Lublin, Staszica 16 Str., 20-081 Lublin, Poland.
Abstract:
Endometriosis involves oestrogen-dependent chronic inflammation and the abnormal proliferation of ectopic endometrial tissue. Conventional hormonal therapies suppress systemic oestrogen, but do not fully address local oxidative and inflammatory signalling. This review provides a mechanistic synthesis of recent molecular evidence. This evidence is on four FDA-recognized (Food and Drug Administration) medicinal plants. These are Curcuma longa, Zingiber officinale, Glycyrrhiza glabra, and Silybum marianum. The review highlights their capacity to modulate key intracellular pathways. These pathways are implicated in endometriosis. The review covers the integration of phytochemical-specific actions within NF-κB- (nuclear factor kappa-light-chain-enhancer of activated B cells), COX-2-(Cyclooxygenase-2), PI3K/Akt-(PI3K/Akt signaling pathway), Nrf2/ARE-(Nuclear factor erythroid 2-related factor 2) and ERβ-(Estrogen receptor beta) mediated networks, which jointly regulate cytokine secretion, apoptosis, angiogenesis and redox balance in endometrial lesions. Curcumin downregulates COX-2 and aromatase while activating Nrf2 signalling, shogaol from ginger suppresses prostaglandin synthesis and induces caspase-dependent apoptosis, isoliquiritigenin from liquorice inhibits HMGB1-TLR4-NF-κB (High Mobility Group Box 1, Toll-like receptor 4) activation, and silymarin from milk thistle reduces IL-6 (Interleukin-6) and miR-155 (microRNA-155) expression while enhancing antioxidant capacity. Together, these phytochemicals demonstrate pharmacodynamic complementarity with hormonal agents by targeting local inflammatory and oxidative circuits rather than systemic endocrine axes. This mechanistic framework supports the rational integration of phytotherapy into endometriosis management and identifies redox-inflammatory signalling nodes as future translational targets.
Insights
This review explores how four medicinal plants, including turmeric and ginger, can target inflammation and oxidative stress in endometriosis. These natural compounds offer complementary approaches to traditional hormonal therapies for managing endometriosis.
Area of Science:
- Phytochemistry and Molecular Biology
- Endocrinology and Reproductive Medicine
Background:
- Endometriosis is characterized by estrogen-dependent inflammation and abnormal endometrial tissue growth.
- Current hormonal therapies primarily suppress systemic estrogen, often failing to address local inflammatory and oxidative stress pathways.
- There is a need for therapeutic strategies that target localized molecular signaling in endometriosis.
Purpose of the Study:
- To synthesize molecular evidence on four FDA-recognized medicinal plants for endometriosis.
- To highlight the capacity of phytochemicals from Curcuma longa, Zingiber officinale, Glycyrrhiza glabra, and Silybum marianum to modulate key intracellular pathways implicated in endometriosis.
- To provide a mechanistic framework for integrating phytotherapy into endometriosis management.
Main Methods:
- Review of molecular evidence on the mechanisms of action of phytochemicals from selected medicinal plants.
- Analysis of how these phytochemicals interact with intracellular pathways such as NF-κB, COX-2, PI3K/Akt, Nrf2/ARE, and ERβ.
- Examination of the impact on cytokine secretion, apoptosis, angiogenesis, and redox balance in endometrial lesions.
Main Results:
- Curcumin (Curcuma longa) downregulates COX-2 and aromatase, activating Nrf2 signaling.
- Shogaol (Zingiber officinale) suppresses prostaglandin synthesis and induces apoptosis.
- Isoliquiritigenin (Glycyrrhiza glabra) inhibits HMGB1-TLR4-NF-κB activation, and silymarin (Silybum marianum) reduces IL-6 and miR-155 while enhancing antioxidant capacity.
- These phytochemicals target local inflammatory and oxidative circuits, complementing hormonal agents.
Conclusions:
- Phytochemicals from turmeric, ginger, liquorice, and milk thistle demonstrate pharmacodynamic complementarity with hormonal therapies.
- These natural compounds target local inflammatory and oxidative signaling pathways, rather than systemic endocrine axes.
- Redox-inflammatory signaling nodes represent promising future targets for endometriosis treatment.
More Related Videos
08:16Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis
Published on: February 26, 2019
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
